At the end of 2015, Austin Frakt, a health economist, researcher, and contributor to The New York Times’ The Upshot, wrote about the life sciences industry’s lack of interest in developing medicines that prevent cancer. It boils down to this: There’s very little incentive for drug companies – they simply make more money prolonging a […]
